Skip to content

Statins and Tinnitus: What a 90,000-Patient Study Found

Tinnitus Clarified Editorial4 min readUpdated September 3, 2026

The article on ototoxic medications covers hearing-related drug side effects broadly. Statins deserve their own look because a large, recent analysis gives unusually specific numbers — including differences between individual statins that are worth knowing if you're on one.

What the largest recent study found

A 2025 retrospective cohort study used the National Institutes of Health's "All of Us" database — a research program representing over 710,000 US participants — to examine 90,271 patients with hyperlipidemia (high cholesterol). The analysis found statin use was associated with higher odds of both sensorineural hearing loss (odds ratio 1.60) and tinnitus (odds ratio 1.36) compared to non-use.

Not all statins showed the same association

The study's most practically useful finding is that the six commonly prescribed statins didn't behave uniformly. Simvastatin showed the strongest association with both hearing loss (odds ratio 1.56) and tinnitus (odds ratio 1.50). Atorvastatin — the most widely prescribed statin — showed a more moderate association (hearing loss 1.27, tinnitus 1.21). Fluvastatin showed the weakest association with hearing loss (1.15) and no statistically significant association with tinnitus at all (1.02, not significant). This kind of drug-by-drug breakdown is exactly the detail that's easy to lose in a general "statins and tinnitus" search, and it's the most actionable part of this research.

Why this doesn't mean statins definitely cause tinnitus

This was an observational cohort study, not a randomized controlled trial — the authors themselves note it cannot establish causation, and residual confounding is a real concern. People prescribed statins already have cardiovascular risk factors (high cholesterol, often blood pressure issues, sometimes diabetes) that are independently associated with tinnitus, covered elsewhere on this site. Some of the observed association could reflect the underlying condition statins are prescribed for, not the medication itself. That said, a sample of over 90,000 people with consistent, dose-independent findings across the statin class is a meaningfully stronger signal than a handful of case reports.

A note on conflicting older research

It's worth being upfront that the literature here isn't unanimous. Other, smaller studies — including one hospital-based study specifically in diabetic patients — found most statins associated with reduced risk of hearing loss or tinnitus, with only fluvastatin and pravastatin as exceptions. This kind of contradiction between studies is common in observational pharmacoepidemiology and is part of why the 2025 All of Us analysis, with its much larger sample, is treated here as the more weight-bearing source — not because older, smaller findings are wrong, but because they're more susceptible to the specific population studied.

What this means practically

  • Statins remain, overall, medications with strong evidence for reducing cardiovascular risk — this isn't a reason to stop one without talking to your doctor, given the more immediate risks of untreated high cholesterol
  • If you started a statin and noticed new tinnitus afterward, that timing is worth mentioning specifically to your prescriber — the drug-specific differences found here (simvastatin showing the strongest association, fluvastatin the weakest) are relevant context for whether an alternative is reasonable
  • This is an association, not proven causation — don't assume a statin is the cause without ruling out the more common causes covered throughout this site first
  • Never stop a prescribed statin abruptly on your own — any change should go through the prescribing physician, weighing the cardiovascular benefit — see the article on tinnitus and blood pressure — against this observational signal

The practical takeaway

The largest recent analysis of statins and tinnitus — 90,271 patients via NIH's All of Us database — found a real, statistically significant association, with meaningful differences between individual statins (simvastatin highest, fluvastatin lowest to none). It's an observational signal, not proof of causation, but it's specific and large enough to be worth a conversation with your doctor if new tinnitus followed starting a statin.

Sources

  1. Statins and Their Effect on Hearing: An All of Us Database Study, Homer et al. (2025)
  2. Association between Statin Use and Sensorineural Hearing Loss in Type 2 Diabetic Patients: A Hospital-Based Study, PMC

Frequently asked questions

Do statins cause tinnitus?+

The largest recent analysis found an association, not proof of cause. A 2025 retrospective cohort study using the NIH All of Us database examined 90,271 patients with high cholesterol and found statin use associated with higher odds of sensorineural hearing loss (odds ratio 1.60) and tinnitus (odds ratio 1.36) compared with non-use. The authors themselves note the design cannot establish causation, and residual confounding is a genuine concern: people prescribed statins already carry cardiovascular risk factors that are independently associated with tinnitus.

Do all statins carry the same association?+

No, and this is the most practically useful part of that study. Simvastatin showed the strongest association with both hearing loss (1.56) and tinnitus (1.50). Atorvastatin, the most widely prescribed, was more moderate (1.27 and 1.21). Fluvastatin was weakest for hearing loss (1.15) and showed no statistically significant association with tinnitus at all (1.02). That drug-by-drug breakdown is exactly what a general search on this topic tends to lose.

Does other research agree?+

Not entirely, and that is worth being upfront about. Other, smaller studies — including a hospital-based study specifically in diabetic patients — found most statins associated with reduced risk of hearing loss or tinnitus, with fluvastatin and pravastatin as the exceptions. Contradictions of this kind are common in observational pharmacoepidemiology. The 2025 analysis is treated as the more weight-bearing source here because of its much larger sample, not because the smaller findings are wrong.

Should I stop my statin?+

Not on your own, and not on the strength of this. Statins have strong evidence behind them for reducing cardiovascular risk, and untreated high cholesterol carries more immediate danger than an observational tinnitus signal. If new tinnitus followed starting one, raise the timing with your prescriber — the differences between individual statins above are relevant context for whether switching to another is reasonable.